Caitlin McNulty
Allergy & Immunology · Rochester, MNNPI 1467895680
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations.
Across 57 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$113
- Octapharma USA, Inc.$108
- Pfizer$76
- Amgen$72
- Teva Pharmaceuticals USA, Inc.$65
- Philips North America LLC$58
- plus $475 from 15 others
Across 1 payment — averaging $215.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$216
What the payments were for
- Food & beverage$966100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $113 |
| Octapharma USA, Inc. | 3 | $108 |
| Pfizer | 5 | $76 |
| Amgen(2 entities) | 5 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Philips North America LLC | 4 | $58 |
| Sanofi | 4 | $57 |
| AstraZeneca | 4 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Genentech USA, Inc. | 2 | $40 |
| Biocryst US Sales Co., LLC | 2 | $39 |
| Pharming Healthcare, Inc. | 2 | $35 |
| Kaleo, Inc. | 2 | $35 |
| GSK | 2 | $33 |
| Phadia US Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Merck | 1 | $19 |
| Advanced Respiratory, Inc | 1 | $18 |
| LEO Pharma Inc. | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $13 |
| Incyte Corporation | 1 | $12 |
How this compares
$966 in reported general payments places this provider in the 60th percentile of 57 allergy & immunology providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 24 | $6,872 |
| Mometasone Furoate | 14 | $1,311 |
| Montelukast Sodium | 12 | $102 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Rochester
- Thanai PongdeeRochester$58K
- Elina JerschowRochester$45K
- David LoweRochester$18K
- Dayne VoelkerRochester$8K
- Michael D'nettoRochester$2K
- Sergio ChiarellaRochester$1K
- Elizabeth EnderRochester$815
- Andrea SitekRochester$427
- Phillip LinkRochester$213
- James LiRochester$134
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.